Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de John Irving Bell
Age : 69
Public asset : 1,208,380 USD
Linked companies : Immunocore Holdings plc
Summary 
Dr. John I. Bell, MD, is a Non-Executive Chairman at Immunocore Ltd., a Chairman-Partnership Board at Oxford Centre for Diabetes Endocrinology & Metabolism, a Chairman at GMEC Management Co. Ltd., a Chairman at Office for Strategic Co-ordination of Health Research, a Chairman at The Oxford Health Alliance and a Non-Executive Director at The Jenner Institute Laboratories.

He is on the Board of Directors at Immunocore Holdings Plc, Genentech, Inc., Genomics England Ltd., Oxford University Hospitals NHS Trust, The Gray Laboratory Cancer Research Trust, Rhodes Trust and The Ewelme Almshouse Charity. Dr. Bell was previously employed as a President by Academy of Medical Sciences, a Non-Executive Director by Roche Holding AG, a Non-Executive Director by Oxagen Ltd., a Founder by The Wellcome Trust Centre for Human Genetics, a Chairman-Medicine Department & Professor by University of Oxford, an Independent Non-Executive Director by Avidex Ltd., a Non-Executive Director by F. Hoffmann-La Roche Ltd., and a Chairman by Sensyne Health Plc.

He also served on the board at Atopix Therapeutics Ltd. and Powderject Pharmaceuticals Plc.

He received his undergraduate degree from Magdalen College School Oxford Ltd, an undergraduate degree from the University of Alberta and a doctorate degree from Magdalen College School Oxford Ltd.


Current positions of John Irving Bell 
NameTitle Since
Immunocore Holdings plc
(Biotechnology & Medical Research)
Non-Executive Director 2015
The Oxford Health Alliance Chairman -
GMEC Management Co. Ltd. Chairman -
Office for Strategic Co-ordination of Health Research Chairman -
Genentech, Inc. Director 2009
Rhodes Trust Trustee -
Oxford University Hospitals NHS Trust Non-Executive Director -
The Gray Laboratory Cancer Research Trust Non-Executive Director -
The Ewelme Almshouse Charity Trustee -
Genomics England Ltd. Non-Executive Director -
The Jenner Institute Laboratories Non-Executive Director 2013
Oxford Centre for Diabetes Endocrinology & Metabolism Chairman-Partnership Board 1999


Holdings of John Irving Bell 
NameEquities%Valuation
Sensyne Health plc (SENS)
(Software)
359,2890.22%709,714 USD
Immunocore Holdings Plc13,4520.033%498,666 USD


John Irving Bell: Personal Network 
Most Read News 
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
More news


© 2021 People and Ownership :   
John Irving Bell : Connections